Skip to content
Back to Analysis
PrecisePK Therapeutic Drug Monitoring Software logo

PrecisePK Therapeutic Drug Monitoring Software

Learn more →

Description

A leading Bayesian therapeutic drug monitoring software for Model-Informed Precision Dosing (MIPD), specializing in vancomycin AUC dosing and featuring real-time monitoring and data-driven analytics for acute kidney injury management.

Market positioning

Leading therapeutic drug monitoring software with strong focus on vancomycin dosing and Bayesian precision dosing

Target audience

Medical and pharmaceutical professionals, pediatricians, neonatologists, pharmacists, and hospital clinical staff involved in therapeutic drug monitoring

Use cases

Model-Informed Precision Dosing (MIPD) for therapeutic drug monitoring, specializing in vancomycin AUC dosing with real-time monitoring and acute kidney injury management

Company information

Company size

Small to Medium Enterprise (estimated 50-200 employees)

Revenue

$5M - $25M (estimated based on specialized healthcare software market)

Scale

Healthcare institutions and hospitals globally

Number of users

Thousands of healthcare professionals across multiple institutions

Features

Acute Kidney Injury (AKI) prediction tool, Bayesian-guided precision dosing, Integration with patient characteristics and lab results, Model-Informed Precision Dosing (MIPD), Multi-language support (English, Spanish, Chinese, Thai, Korean), Multiple drug modules, Real-time monitoring and analytics, SOC2 and ISO/IEC 27001 compliance, User-friendly interface with minimal training required, Vancomycin AUC dosing calculator

Pricing

Pricing modelSubscription-based
Starting priceContact for pricing (estimated $10,000-$50,000 annually per institution)
Billing periodAnnual (estimated)

Rating

4.5/5 (estimated based on specialized healthcare software standards)

No Trustpilot link available

Pros and cons

Based on: (AI summary)

Pros

  • Industry-leading vancomycin AUC dosing accuracy
  • Validated by independent research
  • Endorsed by GlobalRPH
  • Fully compliant with 2020 ASHP/IDSA Vancomycin Guidelines
  • Established history in the industry (formerly TDMS)

Cons

  • Pricing information not readily available
  • May require subscription commitment
  • Primarily focused on vancomycin monitoring

Feature Comparison

Top features across 5 competitors (most common first)

Feature PrecisePK T…Simcyp Pedi…Clinical Ph…Model-Infor…Physiologic…
immunosuppressives
biologics
Acute Kidney Injury (AKI) prediction tool
Bayesian-guided precision dosing
Model-Informed Precision Dosing (MIPD)
Multi-language support (English
Spanish
Chinese
Thai
Korean)
Multiple drug modules
Real-time monitoring and analytics
SOC2 and ISO/IEC 27001 compliance
Vancomycin AUC dosing calculator
Advanced PBPK modeling and simulation
Pediatric population modeling
Diverse population analysis
Drug behavior prediction
Advanced simulation capabilities
Regulatory-ready modeling